<DOC>
	<DOC>NCT00170820</DOC>
	<brief_summary>The purpose of this study is to assess if a combination of everolimus, steroids, and mycophenolate mofetil is associated with a better renal function than sirolimus.</brief_summary>
	<brief_title>Efficacy and Safety of the Switch From Sirolimus to Everolimus in Stable Maintenance Renal Transplant Patients Receiving a Calcineurin Inhibitor Free Regimen</brief_title>
	<detailed_description />
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Calcineurin Inhibitors</mesh_term>
	<criteria>First or second renal transplantation (1 to 10 years posttransplant) Treatment with sirolimus + mycophenolate mofetil + steroids + ACE inhibitor or angiotensin II receptor antagonist + statin Exclusion Criteria Treatment with a CNI or azathioprine Vascular rejection or biopsyproven acute rejection within 3 months prior to screening Severe dyslipidemia Other protocoldefined inclusion / exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Renal transplantation, maintenance, switch, everolimus, CNI-free</keyword>
</DOC>